Updated: May 15, 2021 20:14 IST
Dehradun (Uttarakhand) [India]May 15 (ANI): case mucormycosis in which the patient recovered from COVID-19 at the end of April it was reported on Max Hospital in Dehradun– said the Minister of Health Uttarakhanda Pankaj Pandey.
He also said that two other patients with similar symptoms have already been discharged from the hospital after treatment.
Three patients at Dong Hospital as well as Max Hospital in Dehradun “showed symptoms of the disease,” said Pandy.
The health minister said he has requested advice from a technical committee chaired by HNB Medical University Vice Chancellor Dr. Hem Chandra to prevent complications from COVID.
According to the Union Ministry of Health, mucormycosis or black fungus is a complication caused by a fungal infection. People catch mucormycosis coming into contact with fungal spores in the environment. It can also develop on the skin after the fungus enters the skin through a cut, scrape, burn, or other type of skin injury.
The disease is detected in patients recovering or recovered from COVID-19… Moreover, anyone with diabetes and whose immune system is not functioning properly should beware of this, the ministry said.
It was further stated that the disease is caused by a set of microorganisms known as mucormycetes, which are naturally present in the environment, mainly in soil and decaying organic matter such as leaves, compost and piles.
Normally, our body’s immune system successfully fights off such fungal infections. However, we know that COVID-19 affects our immune system, the ministry said.
He stated that the treatment COVID-19 Patients are taking medications such as dexamethasone, which suppress the response of our immune system. Due to these factors, COVID-19 patients again face the risk of failing to combat attacks from organisms such as mucormycetes.
In addition, COVID patients undergoing oxygen therapy in an intensive care unit where a humidifier is used are prone to fungal infection due to exposure to moisture, the ministry said.
But this does not mean that every COVID patient will contract mucormycosis. The disease is rare in people without diabetes but can be fatal if not treated promptly. It states that the chances of recovery depend on early diagnosis and treatment.
According to the Union’s Ministry of Health, although the infection may only begin with a skin infection, it can spread to other parts of the body. Treatment involves the surgical removal of all dead and infected tissue.
In some patients, this can lead to loss of the upper jaw and sometimes the eye. Treatment may also include a 4 to 6 week course of intravenous antifungal therapy. Because it affects different parts of the body, treatment requires a team of microbiologists, therapists, neurologists-resuscitators, ENT specialists, ophthalmologists, dentists, surgeons and others, he added. (ANI)
Disclaimer: The facts and opinions appearing in the article do not reflect the views of Rv Article and Rv Article does not assume any responsibility or liability for the same.